- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
PharmaBlock Sciences Nanjing Inc Class A (300725)
Assess today's live PharmaBlock Sciences Nanjing Inc Class A (300725) share price, performance and insights using our live Shenzhen: 300725 stock exchange data.
Analyse the historical data and PharmaBlock Sciences Nanjing Inc Class A share price performance charts on this page. Our technical summary section provides analysis on PharmaBlock Sciences A share price buy/sell indicators using real-time data (or discuss the PharmaBlock Sciences A (300725) stock price today with other investors in the PharmaBlock Sciences A SZ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SZ 300725 share price (ISIN: CNE1000035K5) to enhance your trading decisions with our free investment tools and resources.
What Is the PharmaBlock Sciences Nanjing Inc Class A Share Price Today?
The PharmaBlock Sciences A share price today is 42.93.
What Is the Stock Symbol for PharmaBlock Sciences Nanjing Inc Class A
The stock symbol (or 'ticker') for PharmaBlock Sciences Nanjing Inc Class A is "300725."
What Stock Exchange Does PharmaBlock Sciences Nanjing Inc Class A Trade On?
PharmaBlock Sciences Nanjing Inc Class A is listed and trades on the Shenzhen stock exchange.
Is PharmaBlock Sciences Nanjing Inc Class A a Good Stock to Buy?
Determining whether PharmaBlock Sciences Nanjing Inc Class A—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and PharmaBlock Sciences Nanjing Inc Class A share price performance charts on this page. Our technical summary section provides analysis on PharmaBlock Sciences A share price buy/sell indicators using real-time data (or discuss the PharmaBlock Sciences A (300725) stock price today with other investors in the PharmaBlock Sciences A SZ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SZ 300725 share price (ISIN: CNE1000035K5) to enhance your trading decisions with our free investment tools and resources.
What Is the PharmaBlock Sciences Nanjing Inc Class A Share Price Today?
The PharmaBlock Sciences A share price today is 42.93.
What Is the Stock Symbol for PharmaBlock Sciences Nanjing Inc Class A
The stock symbol (or 'ticker') for PharmaBlock Sciences Nanjing Inc Class A is "300725."
What Stock Exchange Does PharmaBlock Sciences Nanjing Inc Class A Trade On?
PharmaBlock Sciences Nanjing Inc Class A is listed and trades on the Shenzhen stock exchange.
Is PharmaBlock Sciences Nanjing Inc Class A a Good Stock to Buy?
Determining whether PharmaBlock Sciences Nanjing Inc Class A—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Shenzhen
Currency in CNY
42.93
-1.33(-3.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.82
44.20
52 wk Range
27.07
53.54
300725 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.8244.20
52 wk Range
27.0753.54
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.63%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.63%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
300725 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
47.00
Upside
+9.48%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
PharmaBlock Sciences A Company Profile
PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment-based drug discovery, DNA encoded library technology, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and full time equivalent (FTE). The company also provides small molecule drug substance CDMO services, including optimal route scouting; FFS and FTE for process research and development of RSMs, intermediates, and APIs; impurity studies and synthesis; solid state chemistry; analytical development and quality control; cGMP manufacturing of intermediates and APIs; and CMC regulatory filing support. In addition, it offers small molecule DP CDMO services, such as candidate screening and selection, early development, full development, registration, and post-approval; and new modality services, including target protein degrader, peptide, oligonucleotide, and ADC services. PharmaBlock Sciences (Nanjing), Inc. was founded in 2006 and is based in Nanjing, the People's Republic of China.
Compare 300725 to Peers and Sector
Metrics to compare | 300725 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300725PeersSector | |
|---|---|---|---|---|
P/E Ratio | 51.3x | 40.9x | −0.6x | |
PEG Ratio | 3.53 | −1.50 | 0.00 | |
Price/Book | 1.4x | 2.9x | 2.6x | |
Price / LTM Sales | 5.2x | 5.9x | 3.4x | |
Upside (Analyst Target) | 6.2% | 24.6% | 39.6% | |
Fair Value Upside | Unlock | 10.5% | 5.2% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 47.00
(+9.48% Upside)
Earnings
Latest Release
Oct 30, 2025
EPS / Forecast
0.20 / --
Revenue / Forecast
499.33M / --
FAQ
What Is the PharmaBlock Sciences A (300725) Share Price Today?
The live PharmaBlock Sciences A share price today is 42.93
What Stock Exchange Does PharmaBlock Sciences A (300725) Trade On?
PharmaBlock Sciences A is listed and trades on the Shenzhen Stock Exchange.
What Is the Ticker (Stock Symbol) for PharmaBlock Sciences A?
The stock symbol (also called a 'ticker') for PharmaBlock Sciences A is "300725."
Does PharmaBlock Sciences A Pay Dividends? What’s The Current 300725 Dividend Yield?
Yes, 300725 Pays Dividends to its Shareholders. The current PharmaBlock Sciences A dividend yield is 0.63%.
What Is the Current PharmaBlock Sciences A Market Cap?
As of today, PharmaBlock Sciences A market capitalisation is 10.00B.
What Is PharmaBlock Sciences A's (300725) Earnings Per Share (TTM)?
The PharmaBlock Sciences A EPS is currently 1.00 (Trailing Twelve Months).
When Is the Next PharmaBlock Sciences A Earnings Date?
PharmaBlock Sciences A's next earnings report will be released on 30 Oct 2025.
Is 300725 a Buy or Sell From a Technical Analyst Perspective?
Based on today's PharmaBlock Sciences A moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has PharmaBlock Sciences A Stock Split?
PharmaBlock Sciences A has split 3 times. (See the 300725 stock split history page for full effective split date and price information.)
How Many Employees Does PharmaBlock Sciences A Have?
PharmaBlock Sciences A has 2455 employees.
What is the current trading status of PharmaBlock Sciences A (300725)?
As of 19 Jan 2026, PharmaBlock Sciences A (300725) is trading at a price of 42.93, with a previous close of 44.26. The stock has fluctuated within a day range of 42.82 to 44.20, while its 52-week range spans from 27.07 to 53.54.
What Is PharmaBlock Sciences A (300725) Price Target According to Analysts?
The average 12-month price target for PharmaBlock Sciences A is CNY47, with a high estimate of CNY47 and a low estimate of CNY47. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +9.48% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.